Nifty Pharma Stocks List – Latest Pharma Index Shares

Nifty Pharma Index Analysis

My Analysis of the Nifty Pharma Index

As of May 30, 2025

I've taken a deep look into the Nifty Pharma Index, a specialized index from the NSE that I find essential for tracking the health of the Indian pharmaceutical sector. It comprises 20 key pharma companies, making it a concentrated but powerful benchmark.

The index is calculated using a Periodic Capped Free Float market capitalization method. This is an important detail for me, as the capping (33% for a single stock, 62% for the top 3) prevents any single heavyweight from dominating the index's direction, ensuring a more balanced representation. My analysis uses the Total Returns Index variant, which I prefer because it accounts for dividends.

Key Performance & Fundamental Metrics

Here's a snapshot of the vital stats. The returns look solid over the long term, and the fundamentals give a sense of the sector's current valuation.

Total Return (1 Year)

+14.82%

Total Return (5 Yr CAGR)

+17.84%

P/E Ratio

30.7

P/B Ratio

5.26

Dividend Yield

0.65%

Beta (vs NIFTY 50)

0.63

Index Performance Visualized

To understand the index's journey, I've plotted its historical performance and its composition. The long-term chart shows a consistent, upward trend, reinforcing the defensive yet growth-oriented nature of the pharma sector. The weightage chart highlights its top-heavy structure, even with capping rules in place.

Historical Performance (Since 2002)

Top 10 Constituents by Weightage (%)

1-Year Return vs. Other Sectors (%)

Full Constituent List (20 Stocks)

Below is the complete list of the 20 companies that make up the Nifty Pharma Index, along with their latest stock prices. I find this list crucial for understanding exactly which companies are driving the index's performance. You can search or sort the table to explore the data.

Company Name	Symbol	Price (INR) As of 21 May, 2025

My Notes on the Index Methodology

I always examine the rulebook. For the Nifty Pharma Index, the selection criteria are quite stringent, which ensures quality and liquidity.

Universe: Companies must be part of the Nifty 500 at the time of review.
Sector: Must belong to the pharmaceutical sector.
Trading Frequency: A minimum of 90% trading frequency in the last six months is required.
Listing History: Must have at least a 1-month listing history.
Preference: A preference is given to stocks that are also traded in the Futures & Options segment, which I see as a proxy for high liquidity and investor interest.
Rebalancing: The index is rebalanced semi-annually (on Jan 31 and Jul 31) to reflect market changes.

Also Read: Best Low PE Ratio Stocks in India to Buy in 2025

Also Read:

Nifty Microcap 250 Stock List with Prices & Updates